Twist Bioscience Corporation (TWST) Tops Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Twist Bioscience Reports Second Quarter 2022 Financial Results
May 5, 2022 4:05 PM EDT-- Record revenue of $48.1M in 2QFY22; Increase of 54% over $31.2M in Fiscal 2021
-- Orders Increased 32% in 2QFY22 over Fiscal 2021 to $55.0M --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality... More
